You searched for "Cognition"
Bringing ear care and hearing services to the hardest to reach: the potential of primary healthcare workers
Can workers from the local community plug the workforce gap in providing ear and hearing care? Bringing ear and hearing care services closer to the community remains a key component of reducing the burden of ear and hearing conditions across...Adult speech testing in the UK
What do hearing healthcare providers see as the benefits and barriers to delivering speech testing? This article explores the latest research. Why speech testing? Speech tests have been used across ENT and audiology practice to measure an individual’s speech recognition...Labour rights violations in the manufacture of healthcare goods
Every year trillions of dollars are spent on medical supplies globally. The operating theatre is a significant proportion of this spend, typically accounting for a third of a hospital’s supply costs. When making purchasing decisions consideration is given to value...Health related quality of life measures as outcome parameters in middle ear diseases
Surely the only outcome needed for post-surgical ears is a better PTA? Marcus Neudert argues there should be more to it than that. To draw a comprehensive picture of the disease-associated restrictions in patients with chronic otitis media, audiometric outcome...ESSD 2023 13th Annual Congress
Emilien Chabrillac, MD, PhD student, specialising in head and neck cancer surgery and oncorehabilitation, Cancer University Institute of Toulouse Oncopole. The recent congress of the European Society for Swallowing Disorders was a remarkable gathering that brought together an array of...FDA Approved Lenire Expands Number of US Clinics
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications
Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.Transferable skills in audiology: one audiologist’s journey
Ever wonder about transferable skills in audiological practice? In this issue, we hear about one audiologist’s journey from clinical practice to applying transferable skills gained in audiology to other healthcare sectors. In 1997, as a 16-year-old starting my career in...The Graham Fraser Foundation
Graham Fraser (1936-94) was a pioneering otolaryngologist, in whose memory the Graham Fraser Foundation was set up, and an eponymous annual lecture and a travelling fellowship in otology were established. It’s an honour to profile the Foundation in this extended...Measuring audiological outcomes in the paediatric setting
In this article Marlene Bagatto argues that a range of outcome measures and instruments need to be implemented when working with children and families. She demonstartes how these support both clinicians and families. The primary goal of early hearing detection...
